Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:1512-1518
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kugiyama, K.
Right arrow Articles by Yasue, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kugiyama, K.
Right arrow Articles by Yasue, H.

Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels

Kiyotaka Kugiyama, MDa, Takeshi Motoyama, MDa, Hideki Doi, MDa, Hiroaki Kawano, MDa, Nobutaka Hirai, MDa, Hirofumi Soejima, MDa, Yuji Miyao, MDa, Keiji Takazoe, MDa, Yasushi Moriyama, MDa, Yuji Mizuno, MDa, Ryusuke Tsunoda, MDa, Hisao Ogawa, MDa, Tomohiro Sakamoto, MDa, Seigo Sugiyama, MDa and Hirofumi Yasue, MDa

a Department of Cardiovascular Medicine, Kumamoto University School of Medicine, Kumamoto, Japan



View larger version (18K):

[in a new window]
 
Figure 1 Percentage increase in brachial arterial diameter from baseline during reactive hyperemia before and after treatment with alpha-tocopherol (open circles) or placebo (closed circles) in patients with high remnant lipoproteins levels (n = 20 patients in each treatment) and in those with low remnants levels (n = 15 patients in each treatment). Significant effect of alpha-tocopherol treatment was observed in patients with high remnant lipoproteins levels as compared with that of placebo but not in those with low remnants levels (by two-way analysis of variance followed by post hoc testing with Scheffé test).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement